Darwin Bioprospecting Excellence
PrivateLast Round
VC Round
Feb 6, 2025
Total Funding Raised
$836,000
Company Overview
Darwin Bioprospecting Excellence operates in Healthcare & Life Sciences and is based in Paterna. Its latest recorded funding round was a VC Round in February 2025.
Darwin Bioprospecting Excellence is a biotechnology company that provides a bioprospecting platform for microbial research for the medical, food, and agriculture sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Darwin Bioprospecting Excellence Comparables
Compare Darwin Bioprospecting Excellence with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Apoena Biotech | 78% | |
| Pluton Biosciences | 77% | |
| BRAIN Biotech AG | 73% |
For institutional investors. Book with your work email.
Darwin Bioprospecting Excellence Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 6, 2025 | ||||
| Grant | Mar 7, 2024 | ||||
| Grant | Oct 5, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Darwin Bioprospecting Excellence Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ICEX Spain Export and Investment | Grant |
| European Regional Development Fund | Grant |
| Biozell Ventures | VC Round |
| Repsol Corporate Venturing | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 137% MoM, reaching 2.9K.
- Nov 8, 2025
Monthly visitors increased 365% MoM, reaching 3.3K.
For institutional investors. Book with your work email.
Darwin Bioprospecting Excellence Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Darwin Bioprospecting Excellence's valuation, stock price, and market status.
Is Darwin Bioprospecting Excellence a public or private company?
Darwin Bioprospecting Excellence is a private company.
What is the current stock price of Darwin Bioprospecting Excellence?
Darwin Bioprospecting Excellence is a private company, so its shares have no public market price. Caplight tracks Darwin Bioprospecting Excellence's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Darwin Bioprospecting Excellence worth (valuation)?
Valuation information for Darwin Bioprospecting Excellence is not publicly available.
Can I buy Darwin Bioprospecting Excellence stock?
Darwin Bioprospecting Excellence shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Darwin Bioprospecting Excellence's last funding round?
Darwin Bioprospecting Excellence's most recent funding round was VC Round on February 6, 2025.
Who are the main investors in Darwin Bioprospecting Excellence?
Key investors in Darwin Bioprospecting Excellence include Repsol Corporate Venturing.
Will Darwin Bioprospecting Excellence IPO soon?
No public IPO plans have been announced for Darwin Bioprospecting Excellence.
How can I track Darwin Bioprospecting Excellence secondary market activity?
Caplight tracks bids, offers, and trades in Darwin Bioprospecting Excellence's shares on secondary markets.